Hydroxyurea (hydroxycarbamide) for transfusion-dependent β-thalassaemia

hydroxyurea treatment in transfusion-dependent β-thalassemia patients

conclusions: hydroxyurea can be safely used in some transfusion-dependent β-thalassemia patients to decrease their transfusion needs. background: β-thalassemia is an inherited hemoglobin disorder caused by defective synthesis of ß-globin chains. hemoglobin (hb) f induction is a possible therapeutic approach which can partially compensate for α and non-α globin chains imbalance. objectives: we a...

Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients

BACKGROUND β-Thalassemia is an inherited hemoglobin disorder caused by defective synthesis of ß-globin chains. Hemoglobin (Hb) F induction is a possible therapeutic approach which can partially compensate for α and non-α globin chains imbalance. OBJECTIVES We aimed to investigate the efficacy and safety of Hydroxyurea (HU) in diminishing transfusion requirements of patients with β-thalassemia...

Liver disease in transfusion dependent thalassaemia major.

AIMS To study the prevalence and severity of liver diseases of transfusion dependent thalassaemia major patients, and correlate the histological and biochemical changes of iron overload in liver with the peripheral blood markers. METHOD Liver biopsy was performed to assess the histological changes and liver iron content (LIC). RESULTS One hundred patients were evaluated (median age 11.7 yea...

Transfusion-dependent thalassaemia: a new era.

1 Royal Australasian College of Surgeons. Surgical Education and Training program. Melbourne: RACS, 2007. http://www.surgeons.org/Content/NavigationMenu/EducationandTraining (accessed Oct 2007). 2 Royal Australasian College of Surgeons. Council highlights August 2007. Melbourne: RACS, 2007. http://www.surgeons.org/Content/NavigationMenu/WhoWeAre/Council/CouncilHighlights/Council_Highlights_Augu...

Guidelines for the Management of Non Transfusion Dependent Thalassaemia (ntdt)